These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12195714)

  • 1. Inhibition of human osteoblast growth by unfractionated heparin and by low molecular weight heparins in vitro.
    Kock HJ; Handschin AE
    Thromb Haemost; 2002 Aug; 88(2):361-2. PubMed ID: 12195714
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteoblast growth inhibition by unfractionated heparin and by low molecular weight heparins: an in-vitro investigation.
    Kock HJ; Handschin AE
    Clin Appl Thromb Hemost; 2002 Jul; 8(3):251-5. PubMed ID: 12361203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.
    Khorana AA; Sahni A; Altland OD; Francis CW
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2110-5. PubMed ID: 12920044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of unfractionated and low-molecular-weight heparin on bone healing: an animal model].
    Kock HJ; Werther S; Uhlenkott H; Taeger G
    Unfallchirurg; 2002 Sep; 105(9):791-6. PubMed ID: 12232738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low-molecular-weight and unfractionated heparin on trophoblast function.
    Quenby S; Mountfield S; Cartwright JE; Whitley GS; Vince G
    Obstet Gynecol; 2004 Aug; 104(2):354-61. PubMed ID: 15292011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High and low molecular weight heparins do not modify red blood cell aggregability in vitro.
    Martínez M; Vaya A; López-Camacho C; Coll-Sangrona E; Mira Y; Aznar J
    Clin Hemorheol Microcirc; 2000; 23(1):67-70. PubMed ID: 11214715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
    Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
    J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin.
    Marchetti M; Vignoli A; Russo L; Balducci D; Pagnoncelli M; Barbui T; Falanga A
    Thromb Res; 2008; 121(5):637-45. PubMed ID: 17692905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fondaparinux compared with dalteparin, enoxaparin and unfractionated heparin on human osteoblasts.
    Matziolis G; Perka C; Disch A; Zippel H
    Calcif Tissue Int; 2003 Oct; 73(4):370-9. PubMed ID: 12874702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-anticoagulant effects of unfractionated and low-molecular weight heparins.
    Walenga JM
    Clin Adv Hematol Oncol; 2007 Oct; 5(10):759-60. PubMed ID: 17998892
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative analysis of unfractionated and low molecular weight heparins on the polymerization process of fibrin].
    Barkagan ZS; Solomina TA
    Biull Eksp Biol Med; 1997 Sep; 124(9):346-7. PubMed ID: 9445624
    [No Abstract]   [Full Text] [Related]  

  • 12. Cbfa-1 (Runx-2) and osteocalcin expression by human osteoblasts in heparin osteoporosis in vitro.
    Handschin AE; Egermann M; Trentz O; Wanner GA; Kock HJ; Zünd G; Trentz OA
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):465-72. PubMed ID: 17000892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
    Fareed J; Jeske W; Fareed D; Clark M; Wahi R; Adiguzel C; Hoppensteadt D
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low doses and high doses of heparin have different effects on osteoblast-like Saos-2 cells in vitro.
    Hausser HJ; Brenner RE
    J Cell Biochem; 2004 Apr; 91(5):1062-73. PubMed ID: 15034940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of unfractionated and fractionated heparins on myeloperoxidase activity and interactions with endothelial cells: possible effects on the pathophysiology of equine laminitis.
    de la Rebière G; Franck T; Deby-Dupont G; Salciccia A; Grulke S; Péters F; Serteyn D
    Vet J; 2008 Oct; 178(1):62-9. PubMed ID: 17942351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of heparin and low molecular weight heparins on platelets.
    Vermylen JG
    Semin Thromb Hemost; 1993; 19 Suppl 1():20-1. PubMed ID: 8395723
    [No Abstract]   [Full Text] [Related]  

  • 17. [Standard heparin and low molecular weight heparins].
    Chojnowski K; Judkiewicz L; Sobol A
    Acta Haematol Pol; 1992; 23(4):207-12. PubMed ID: 1338174
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.
    Vignoli A; Marchetti M; Balducci D; Barbui T; Falanga A
    Haematologica; 2006 Feb; 91(2):207-14. PubMed ID: 16461305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of heparin and low molecular weight heparin on osteoblastogenesis and adipogenesis in vitro.
    Osip SL; Butcher M; Young E; Yang L; Shaughnessy SG
    Thromb Haemost; 2004 Oct; 92(4):803-10. PubMed ID: 15467912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin effect on osteoblast-like cells in vitro.
    Handschin AE; Wanner GA; Trentz OA
    J Cell Biochem; 2004 Sep; 93(1):1. PubMed ID: 15352155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.